Create Account | Sign In: Author or Forum

Search Symptoms

Medical Specialty >> Pharmacy

Millions Get Wrong Treatment for Back Pain: Study

2:00 PM CDT. Read article More Pharmacy News


Dipeptidyl Peptidase-4 Inhibitors in T2DM Linked to IBD

12:00 PM CDT. Higher risk of inflammatory bowel disease with longer use of dipeptidyl peptidase-4 inhibitor


February 2018 Briefing - Pharmacy

March 01, 2018. The Monthly Journal Summary is a single article covering the most important journal articles published in the previous 30 days.


Robert L. Coleman, MD's avatarRucaparib Maintenance Therapy Improves PFS in Platinum-sensitive Ovarian Cancer - The ARIEL3 Trial

Robert L. Coleman, MD. Professor Robert L. Coleman M.D., FACOG, FACS discusses the implications of data from the Phase 3 ARIEL3 trial of the novel PARP inhibitor rucaparib as maintenance therapy in patients with platinum-sensitive ovarian cancer. Professor Coleman is the Vice Chair of Clinical Research in the Department of…

Ted Lain, MD's avatarInvestigational Topical Minocycline Gel for Acne Advances to Phase III Development

Ted Lain, MD. Clinical trial investigator Dr. Ted Lain comments on the results of the OPAL study, a Phase 2b clinical trial which evaluated the efficacy of a novel topical gel formulation of the antibiotic minocycline (BPX-01) in reducing the number of inflammatory lesions in patients with moderate-to-severe inflammatory,…

Dr. Alberto De la Guerra's avatarBevacizumab for breast cancer: FDA grants a stay of execution

Dr. Alberto De la Guerra. The Food and Drug Administration has after repeated delays proposed removing metastatic breast cancer as an indication from the Avastin label. The proposal is being contested by Roche/Genentech, the drug’s maker. In this article we review the evidence for and against this decision.



RE: Investigational Topical Minocycline Gel for Acne Advances to Phase III Development

By MrRobin

Great articles. learnt a lot from it.